Finance
Finance
HomeLAB • NASDAQ
Standard Biotools Inc
$1.51
Nov 28, 12:30:42 PM GMT-5 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$1.43
Day range
$1.45 - $1.56
Year range
$0.92 - $2.25
Market cap
549.93M USD
Avg Volume
2.06M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Sep 2025Y/Y change
Revenue
19.55M-11.47%
Operating expense
32.95M4.92%
Net income
-34.69M-28.77%
Net profit margin
-177.41-45.45%
Earnings per share
-0.04-16.47%
EBITDA
-21.87M-69.40%
Effective tax rate
3.70%
Total assets
Total liabilities
(USD)Sep 2025Y/Y change
Cash and short-term investments
194.90M-46.80%
Total assets
539.64M-20.82%
Total liabilities
139.98M-27.17%
Total equity
399.66M
Shares outstanding
384.57M
Price to book
1.38
Return on assets
-10.70%
Return on capital
-13.33%
Net change in cash
(USD)Sep 2025Y/Y change
Net income
-34.69M-28.77%
Cash from operations
-22.20M20.33%
Cash from investing
-6.68M78.37%
Cash from financing
-112.00K-5,500.00%
Net change in cash
-29.20M50.65%
Free cash flow
-5.09M68.58%
About
Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications. Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations. Wikipedia
Founded
1999
Employees
816
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu